What is Glaukos's EBITDA?

Glaukos (GKOS) reported EBITDA of -$8.06M in Q1 2026.

How has Glaukos's EBITDA changed year-over-year?

Glaukos's EBITDA increased by 35.3% year-over-year, from -$12.45M to -$8.06M.

What is the long-term trend for Glaukos's EBITDA?

Over 4 years (2021 to 2025), Glaukos's EBITDA has grown at a 166.3% compound annual growth rate (CAGR), from -$3.21M to -$161.51M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Glaukos GKOS EBITDA

EBITDA at other companies

Johnson & JohnsonJNJ

——

Regeneron PharmaceuticalsREGN

——

AbbVieABBV

——

Boston ScientificBSX

——

The Cooper Companies, Inc.COO

——

ExelixisEXEL

——

Other financials

Income statement

See full

Revenue$150.6M+41.2%

Gross profit$117.2M+42.4%

Operating income-$19.9M+4.0%

Net income-$19.8M-9.0%

EPS (diluted)-$0.34-6.3%

Balance sheet

See full

Cash & equivalents$104.2M-8.8%

Total debt$105.9M-1.7%

Total equity$670.9M-12.2%

Total assets$893.3M-7.5%

Cash flow

See full

Operating cash flow-$12.5M+32.4%

CapEx$4.0M+104%

Free cash flow-$16.5M+19.4%

Valuation

See full

Market cap$7.68B+12.3%

Enterprise value$7.68B+12.5%

P/S13.9×-3.0×

Profitability

See full

Gross margin78.1%+2.3pp

Operating margin-36.1%+24.3pp

Net margin-34.3%+4.8pp

FCF margin-13.2%-3.9pp

Returns & leverage

See full

Return on equity-26.4%+11.1pp

Debt / equity0.2×0.0×

Current ratio5.4×-1.1×

Where this comes from

Calculated from Glaukos’s reported figures.

−$19.9Mebit+

$11.8MDepreciation Depletion & Amortization

=-$8.06M

The official record: Glaukos’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Glaukos's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Glaukos's EBITDA?: Glaukos (GKOS) reported EBITDA of -$8.06M in Q1 2026.
How has Glaukos's EBITDA changed year-over-year?: Glaukos's EBITDA increased by 35.3% year-over-year, from -$12.45M to -$8.06M.
What is the long-term trend for Glaukos's EBITDA?: Over 4 years (2021 to 2025), Glaukos's EBITDA has grown at a 166.3% compound annual growth rate (CAGR), from -$3.21M to -$161.51M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.